David Lillicrap
@DavidLillicrap
Followers
2K
Following
142
Media
1
Statuses
144
Queen’s U prof researching molecular aspects of blood clotting. Co-Editor in Chief (w/@JHMorrissey) of the Journal of Thrombosis & Haemostasis @JTHjournal
Kingston, Ontario
Joined January 2019
RT @AvaBoutilier1: I’m so unbelievably honoured to receive this award. Thank you to my mentors, past and present, for all of their support….
0
6
0
RT @DrFlashHeart: Sharing our latest work characterizing CHIP as a risk factor for acute kidney injury (AKI) using human cohort data and mo….
0
34
0
Lastly, my thanks to ISTH HQ and especially to @TomReiser for your consistent encouragement of our efforts. The journal is in great hands going forward. Wishing Tom and Suzanne every success with their editorial plans.
This is our last week as EICs of JTH after 5 years of overseeing the direction of this wonderful journal. It’s been an amazing time and a huge privilege to work with @JHMorrissey, the editorial team at J&J and our brilliant group of Associate Editors. Thank you everyone!!.
0
2
15
This is our last week as EICs of JTH after 5 years of overseeing the direction of this wonderful journal. It’s been an amazing time and a huge privilege to work with @JHMorrissey, the editorial team at J&J and our brilliant group of Associate Editors. Thank you everyone!!.
The last weeks of 2023, . We want to THANK our EIC @DavidLillicrap @JHMorrissey for their contribution to our journal!.
3
4
67
Congratulations Dave. So proud of your achievements over the past 25 yrs. I think Ron Worton knew a winner when he saw one.
Most importantly to all the students, PDFs and technicians who make coming to work everyday an exciting and stimulating experience. Without you I would have never done this well!!!.
0
0
5
RT @DPicketts: At the OHRI for 25 years…. dream job. Thanks to my mentors @DavidLillicrap & Doug Higgs; to Ron Worton for taking a chance o….
0
2
0
Stay safe everyone. We are all thinking of you. Such crazy times.
The faculty, staff, and trainees of the Blood Research Center are all safe. Thank you to our friends for reaching out. Please keep @UNC in your thoughts as we move forward after this event.
0
1
12
Anna, this was totally predictable - late to arrive, repetitive and a pain in the a…. to work with!!!!.
Well, this should help us all! 😉.
0
0
7
My pleasure! Hope you enjoyed what was probably the best ISTH congress for a long time. I’m feeling very reinvigorated after the past week.
Thank you for having me @isth2023 it was a wonderful experience for two newcomers! Thank you to @DavidLillicrap as always for being a great mentor and boss! Until next time! ✌🏻🫶🏻😎
0
0
15
An outstanding plenary lecture. Thank you for taking time to visit us. Your talk was a brilliant reminder to everyone , but especially the early career attendees, of how exciting and powerful science can be.
Thank you for highlighting our research! It was a great honor to give the Plenary Alan Giles Memorial Lecture at #ISTH2023 in Montreal. Grateful to @isth @DavidLillicrap @IsthPresident @SusanRKahn1 @RodgerMarc 🙏.
1
3
27
Dr. Cormier…the robes and hat suit you, just not very practical in the lab. Huge congrats and looking forward to celebrating with you in Montreal this week.
1
0
8
Congrats on a very productive and exciting thesis. Now on to more successes!!.
Thrilled to celebrate my #PhD graduation with #Classof2023 in @RCSI_Irl this week. 🥳 🎉Huge thanks to everyone who supported me in this chapter - I couldn’t have done it without you 🙏 #PhinisheD #ittakesavillage @ICATProgramme @ProfJSODonnell @IrishCtrVascBio @RCSIPharmBioMol
0
0
6
Outstanding productivity!! Congrats to all and hope to see some (all) of this work presented at the Montreal congress. Wishing you all continued success in your futures.
0
0
7
0
22
0
Congrats to the 6 very worthy recipients of this year's JTH Editors' Awards. To have your manuscripts accepted for publication, proceed through rounds of review by JTH Associate Editors and Editors-in-Chief and come out as winners is quite the achievement!.
Honoured to have been selected by @JTHjournal for the annual Editors award. Huge thanks to @ICATProgramme, my mentor @ProfJSODonnell and all my colleagues in @IrishCtrVascBio @RCSIPharmBioMol 🙏 Looking forward to #ISTH2023 🇨🇦.
0
2
8
Congratulations and welcome to Suzanne and Ton as the next EIC team @JTHJournal. Jim and I look forward to working with you over the coming months of transition.
ANNOUNCEMENT: We are excited to announce Suzanne Cannegieter, M.D., Ph.D., (@s_cannegieter) and Ton Lisman, Ph.D. as the next @JTHJournal Editors-in-Chief for the 2024-2027 term. Learn more about their vision for JTH at
0
4
24
Wonderful news. Congratulations Mike and to RPTH for choosing one of the very few people who could fill the shoes of the amazing @MaryCushmanMD Much to look forward to.
We're proud to share: Michael Makris, M.D.,(@Profmakris) will be the next @RPTHJournal Editor-in-Chief, guiding the growth of our open access journal. He'll join founding editor, @MaryCushmanMD, until the transition in 2024. Read more: .#EAHAD2023 #EAHAD
1
2
14
A huge pleasure & privilege to work with @JHMorrissey, our amazing team of Associate Editors and James and Tyrra at J&J Editorial. The first of our 20th Anniversary Reviews will be available soon and you’re going to love the exciting topics and stellar cast of authors!.
We're proud to celebrate the 20th anniversary of @JTHJournal. With an all-time high Impact Factor 16.041, the journal continues to grow and publish important research in the field of T&H. Read the editorial from @JHMorrissey and @DavidLillicrap here:
1
3
27
You’ll be a star Matt!! Just think of all the tolerance mechanisms you’ve learnt and do the opposite. Still at least a couple of manuscripts to submit - promise I’ll get there very soon!!.
Excited to announce I will be beginning my postdoctoral fellowship with @brooks_lab at @UHN elucidating the role of interferons in anti-tumour immunity! A different focus than my PhD work, but VERY excited to have the opportunity to work with this great team! 💪
1
0
12
A major message from this long-term study is that although FVIII levels are low (5-10%) they were stable and the dogs didn’t bleed. Just maybe aiming for much higher FVIII levels isn’t such a good idea.
Important paper published in @BloodJournal on the treatment of hemophilic dogs with FVIII gene therapy. Stable FVIII for >10years, clinical efficacy and no liver disease on the liver histology. Paper behind pay-wall. #hemophilia
1
3
25